Our Atlanta location previously on Howell Mill Rd has recently moved to a brand new facility. Here is our new address.
1730 NE Expy NE, Atlanta, GA 30329
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy
Fall 2021 - Winter 2022
The official Newsletter of Rare Disease Research, LLC
Clinical News
What Causes Hereditary Diseases?
A Checklist that Helps Parents to Recognize the First Signs of Serious Neuromuscular Diseases.
Summer - Fall 2021
The official Newsletter of Rare Disease Research, LLC
The official Newsletter of Rare Disease Research, LLC
The official Newsletter of Rare Disease Research, LLC
Friday, February 26, 2021 | 2:00-3:30 PM ET
The official Newsletter of Rare Disease Research, LLC
We invite you to support one of our patients with his fundraiser campaign.
Clinical Study for patients with Tourette Syndrome available at Rare Disease Research.
Make your gift today so that PPMD can maintain their commitment to research, care, and advocacy in the face of the most challenging time we’ve ever experienced.
In the words of one of our patients, Ethan LyBrand, "Through the good times and bad, the Muscular Dystrophy Association helps kids like me."
RDR is closely monitoring the ongoing Coronavirus disease pandemic (2019). As the current situation continues to change, our utmost priority is the health and safety of RDR staff, patients, and their families.
Saturday, March 14, 2020 | Join for a FREE all-day meeting on Duchenne care, comprehensive research updates, and advocacy opportunities – breakfast and lunch are included!
Saturday, March 14, 2020 | Atlanta 2020 MG Walk. A world without MG. Come together to support the MG Community. Register to enter the fight against MG now!
To receive email updates, please enter your email address.
In the United States, a rare disease is defined as disease that affects less than 200,000 people. With 7,000 known rare diseases affecting 30 million Americans and an estimated 350 million people worldwide. Of those statistics, about 75% of rare diseases are children, and about 30% of patients with rare diseases will not live past the age of 5.
In 1983, the FDA approved The Orphan Drug Act which gives incentives to companies that work to develop treatments for rare diseases. Since then, there have been nearly 350 treatments approved for various rare diseases.
Rare Diseases
Affected Americans
Approved Treatments
You or your child’s participation in our research is voluntary, and you are free to withdraw at any time. There will be no penalty or loss of benefits to which are you are otherwise entitled. We may be able to compensate you for your time and travel. Please do not hesitate to call us or send a message. We'll be happy to answer your questions and tell you more about our research.
Call our research team at: 678 - 883 - 6897
If you are experiencing an emergency, please call 911.
Please complete the form below to get more information about available research studies or
to schedule a call.